Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

NEO-MEDROL

METHYLPREDNISOLONE; NEOMYCIN SULFATE

Standard Dose
0.1%;EQ 3.5MG BASE/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEO-MEDROL is listed in Drugs@FDA under application 060645 (ANDA).

Marketing status: Discontinued Active ingredient METHYLPREDNISOLONE; NEOMYCIN SULFATE Form and strength OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview NEO-MEDROL is listed in Drugs@FDA under application 060645 (ANDA). Marketing status: Discontinued Active ingredient METHYLPREDNISOLONE; NEOMYCIN SULFATE Form and strength OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM Sponsor PHARMACIA AND UPJOHN Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.